Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alceco International is a Luxembourg-registered holding and investment company rather than an operating biotech, pharma, or healthcare developer. Publicly available references connect it primarily to shareholdings and financing activity around Oasmia Pharmaceutical/Vivesto and to its association with Julian Aleksov. The company appears in biopharma databases because of those ownership links, but there is no clear evidence that Alceco itself runs an independent therapeutic pipeline, R&D platform, or healthcare services business. Based on available sources, it is best characterized as a private investment vehicle with historical relevance to listed life science companies rather than a standalone life sciences operator.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alceco International.